Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation

Ramalingam Bethunaickan, Ranjit Sahu, Zheng Liu, Yi Ting Tang, Weiqing Huang, Osarieman Edegbe, Haiou Tao, Meera Ramanujam, Michael P. Madaio, Anne Davidson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective. To analyze the mechanism for the therapeutic effects of tumor necrosis factor α (TNFα) inhibition in a murine model of systemic lupus erythematosus. Methods. We used the (NZB × NZW)F1 (NZB/ NZW) mouse model of interferon-α-induced lupus nephritis and treated mice with TNF receptor type II (TNFRII) Ig after TNFα expression was detected in the kidneys. Autoantibodies were measured by enzyme-linked immunosorbent assay (ELISA), and autoantibodyforming cells were determined using an enzyme-linked immunospot assay. Activation of splenocytes was analyzed by flow cytometry. Kidneys were harvested and analyzed using flow cytometry, immunohistochemistry, ELISA, Western blotting, and real-time polymerase chain reaction. Results. TNFRII Ig treatment stabilized nephritis and markedly prolonged survival. Autoantibody production and systemic immune activation were not inhibited, but the renal response to glomerular immune complex deposition was attenuated. This was associated with decreases in renal production of chemokines, renal endothelial cell activation, interstitial F4/80high macrophage accumulation, tubular damage, and oxidative stress. In contrast, perivascular lymphoid aggregates containing B cells, T cells, and dendritic cells accumulated unabated. Conclusion. Our data suggest that TNFα is a critical cytokine that amplifies the response of the nephron to immune complex deposition, but that it has less influence on the response of the systemic vasculature to inflammation.

Original languageEnglish (US)
Pages (from-to)3399-3408
Number of pages10
JournalArthritis and Rheumatism
Volume64
Issue number10
DOIs
StatePublished - Oct 1 2012

Fingerprint

Lupus Nephritis
Antigen-Antibody Complex
Interferons
Tumor Necrosis Factor-alpha
Macrophages
Kidney
Autoantibodies
Flow Cytometry
Enzyme-Linked Immunosorbent Assay
Receptors, Tumor Necrosis Factor, Type II
Therapeutics
Enzyme-Linked Immunospot Assay
Nephritis
Tumor Necrosis Factor Receptors
Nephrons
Therapeutic Uses
Chemokines
Systemic Lupus Erythematosus
Dendritic Cells
Real-Time Polymerase Chain Reaction

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. / Bethunaickan, Ramalingam; Sahu, Ranjit; Liu, Zheng; Tang, Yi Ting; Huang, Weiqing; Edegbe, Osarieman; Tao, Haiou; Ramanujam, Meera; Madaio, Michael P.; Davidson, Anne.

In: Arthritis and Rheumatism, Vol. 64, No. 10, 01.10.2012, p. 3399-3408.

Research output: Contribution to journalArticle

Bethunaickan, Ramalingam ; Sahu, Ranjit ; Liu, Zheng ; Tang, Yi Ting ; Huang, Weiqing ; Edegbe, Osarieman ; Tao, Haiou ; Ramanujam, Meera ; Madaio, Michael P. ; Davidson, Anne. / Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. In: Arthritis and Rheumatism. 2012 ; Vol. 64, No. 10. pp. 3399-3408.
@article{108ba5f4b63941d8b984d74236f6d381,
title = "Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation",
abstract = "Objective. To analyze the mechanism for the therapeutic effects of tumor necrosis factor α (TNFα) inhibition in a murine model of systemic lupus erythematosus. Methods. We used the (NZB × NZW)F1 (NZB/ NZW) mouse model of interferon-α-induced lupus nephritis and treated mice with TNF receptor type II (TNFRII) Ig after TNFα expression was detected in the kidneys. Autoantibodies were measured by enzyme-linked immunosorbent assay (ELISA), and autoantibodyforming cells were determined using an enzyme-linked immunospot assay. Activation of splenocytes was analyzed by flow cytometry. Kidneys were harvested and analyzed using flow cytometry, immunohistochemistry, ELISA, Western blotting, and real-time polymerase chain reaction. Results. TNFRII Ig treatment stabilized nephritis and markedly prolonged survival. Autoantibody production and systemic immune activation were not inhibited, but the renal response to glomerular immune complex deposition was attenuated. This was associated with decreases in renal production of chemokines, renal endothelial cell activation, interstitial F4/80high macrophage accumulation, tubular damage, and oxidative stress. In contrast, perivascular lymphoid aggregates containing B cells, T cells, and dendritic cells accumulated unabated. Conclusion. Our data suggest that TNFα is a critical cytokine that amplifies the response of the nephron to immune complex deposition, but that it has less influence on the response of the systemic vasculature to inflammation.",
author = "Ramalingam Bethunaickan and Ranjit Sahu and Zheng Liu and Tang, {Yi Ting} and Weiqing Huang and Osarieman Edegbe and Haiou Tao and Meera Ramanujam and Madaio, {Michael P.} and Anne Davidson",
year = "2012",
month = "10",
day = "1",
doi = "10.1002/art.34553",
language = "English (US)",
volume = "64",
pages = "3399--3408",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation

AU - Bethunaickan, Ramalingam

AU - Sahu, Ranjit

AU - Liu, Zheng

AU - Tang, Yi Ting

AU - Huang, Weiqing

AU - Edegbe, Osarieman

AU - Tao, Haiou

AU - Ramanujam, Meera

AU - Madaio, Michael P.

AU - Davidson, Anne

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Objective. To analyze the mechanism for the therapeutic effects of tumor necrosis factor α (TNFα) inhibition in a murine model of systemic lupus erythematosus. Methods. We used the (NZB × NZW)F1 (NZB/ NZW) mouse model of interferon-α-induced lupus nephritis and treated mice with TNF receptor type II (TNFRII) Ig after TNFα expression was detected in the kidneys. Autoantibodies were measured by enzyme-linked immunosorbent assay (ELISA), and autoantibodyforming cells were determined using an enzyme-linked immunospot assay. Activation of splenocytes was analyzed by flow cytometry. Kidneys were harvested and analyzed using flow cytometry, immunohistochemistry, ELISA, Western blotting, and real-time polymerase chain reaction. Results. TNFRII Ig treatment stabilized nephritis and markedly prolonged survival. Autoantibody production and systemic immune activation were not inhibited, but the renal response to glomerular immune complex deposition was attenuated. This was associated with decreases in renal production of chemokines, renal endothelial cell activation, interstitial F4/80high macrophage accumulation, tubular damage, and oxidative stress. In contrast, perivascular lymphoid aggregates containing B cells, T cells, and dendritic cells accumulated unabated. Conclusion. Our data suggest that TNFα is a critical cytokine that amplifies the response of the nephron to immune complex deposition, but that it has less influence on the response of the systemic vasculature to inflammation.

AB - Objective. To analyze the mechanism for the therapeutic effects of tumor necrosis factor α (TNFα) inhibition in a murine model of systemic lupus erythematosus. Methods. We used the (NZB × NZW)F1 (NZB/ NZW) mouse model of interferon-α-induced lupus nephritis and treated mice with TNF receptor type II (TNFRII) Ig after TNFα expression was detected in the kidneys. Autoantibodies were measured by enzyme-linked immunosorbent assay (ELISA), and autoantibodyforming cells were determined using an enzyme-linked immunospot assay. Activation of splenocytes was analyzed by flow cytometry. Kidneys were harvested and analyzed using flow cytometry, immunohistochemistry, ELISA, Western blotting, and real-time polymerase chain reaction. Results. TNFRII Ig treatment stabilized nephritis and markedly prolonged survival. Autoantibody production and systemic immune activation were not inhibited, but the renal response to glomerular immune complex deposition was attenuated. This was associated with decreases in renal production of chemokines, renal endothelial cell activation, interstitial F4/80high macrophage accumulation, tubular damage, and oxidative stress. In contrast, perivascular lymphoid aggregates containing B cells, T cells, and dendritic cells accumulated unabated. Conclusion. Our data suggest that TNFα is a critical cytokine that amplifies the response of the nephron to immune complex deposition, but that it has less influence on the response of the systemic vasculature to inflammation.

UR - http://www.scopus.com/inward/record.url?scp=84869015097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869015097&partnerID=8YFLogxK

U2 - 10.1002/art.34553

DO - 10.1002/art.34553

M3 - Article

C2 - 22674120

AN - SCOPUS:84869015097

VL - 64

SP - 3399

EP - 3408

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 10

ER -